Oracle, Intel among market cap stock movers on Monday

Monday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Oracle and Intel are rallying, while stocks like Goldman Sachs are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers ($200 billion USD or higher)

• Oracle Corp (ORCL); Oracle adds document review, inspection tools to Aconex platform: +11.14%
• Intel Corp (INTC): +4.13%
• Microsoft Corp (MSFT); OpenAI touts Amazon alliance in memo, says Microsoft has ’limited our ability’ to reach clients - CNBC: +3.05%
• United Health Group (UNH): +2.26%
• IBM (IBM): +2.46%
• AbbVie Inc (ABBV): -1.91%
• Coca-Cola Co (KO): -1.98%
• Goldman Sachs Group (GS): -2.5%

Large-Cap Stock Movers ($10-$200 billion USD)

• Revolution Medicines Inc (RVMD); Revolution Medicines reports positive phase 3 pancreatic cancer trial: +38.79%
• Avis Budget (CAR): +15.59%
• Credo Technology Holding (CRDO); Jefferies initiates Credo Technology stock with buy rating on AI growth: +10.95%
• Astera Labs (ALAB): +9.11%
• Fair Isaac and Comp Inc (FICO): +9.35%
• Circle Internet Group Inc (CRCL): +9.35%
• CoreWeave (CRWV): +9.08%
• Cloudflare Inc (NET); Cloudflare expands agent cloud infrastructure for AI developers: +9.06%
• Snowflake Inc (SNOW): +8.91%
• Yandex (NBIS); Freedom Capital Markets downgrades Nebius stock rating on valuation concerns: +8.06%

Mid-Cap Stock Movers ($2-$10 billion USD)

• Aeglea Bio Therapeutics Inc (SYRE); Spyre reports positive phase 2 data for ulcerative colitis drug: +26.25%
• Oaktree Acquisition Corp (HIMS): +10.24%
• Rubrik (RBRK): +9.93%
• Braze (BRZE): +9.07%
• Ringcentral Inc (RNG): +8.57%
• SailPoint Tech (SAIL): +8.44%
• Nutanix Inc (NTNX): +8.43%
• Robert Half Intl (RHI): +8.18%
• Tempus AI (TEM); Jefferies initiates Tempus AI stock with underperform rating: +7.73%
• Varonis Systems (VRNS): +7.83%

Small-Cap Stock Movers ($300 million -$2 billion USD)

• Replimune Group Inc (REPL); JPMorgan downgrades Replimune stock rating after second FDA rejection: -65.02%
• Aimei Health Tech (AFJK): -27.56%
• Omnilit Acquisition (OPTX): +22.35%
• MMTEC (MTC): +21.33%
• Allogene Therapeutics Inc (ALLO); Allogene reports interim data from lymphoma trial: +15.26%
• Beta Bionics Inc (BBNX): +18.12%
• Sigma Lithium US (SGML): +17.27%
• Gloo Holdings Ltd (GLOO): +15.73%
• Zentalis Pharmaceuticals LLC (ZNTL): -15.28%
• SNXX (SNXX): +17.39%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.